|
Medical News FDA Finds No Heart Attack Risk With HIV DrugMarch 2, 2011 Food and Drug Administration officials said Tuesday that a data review of the AIDS drug abacavir revealed no greater risk of heart attacks than other HIV medicines. Doctors should continue to prescribe abacavir as directed, the agency said. FDA's analysis included 26 clinical trials and began in 2008 after studies showed conflicting information about a possible link to heart attacks. Abacavir, a nucleoside reverse transcriptase inhibitor, is in the combination treatments Ziagen, Trizivir, and Epzicom. Reuters 03.01.2011 This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
|